HomeCompareMCVEF vs KO

MCVEF vs KO: Dividend Comparison 2026

MCVEF yields 0.62% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KO wins by $13.5K in total portfolio value
10 years
MCVEF
MCVEF
● Live price
0.62%
Share price
$27.25
Annual div
$0.17
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$64.97
Full MCVEF calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — MCVEF vs KO

📍 KO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCVEFKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCVEF + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCVEF pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCVEF
Annual income on $10K today (after 15% tax)
$53.03/yr
After 10yr DRIP, annual income (after tax)
$55.22/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, KO beats the other by $3,603.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCVEF + KO for your $10,000?

MCVEF: 50%KO: 50%
100% KO50/50100% MCVEF
Portfolio after 10yr
$27.3K
Annual income
$2,184.37/yr
Blended yield
8.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

MCVEF
No analyst data
Altman Z
2.3
Piotroski
6/9
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCVEF buys
0
KO buys
0
No recent congressional trades found for MCVEF or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCVEFKO
Forward yield0.62%2.70%
Annual dividend / share$0.17$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$20.6K$34.1K
Annual income after 10y$64.97$4,303.79
Total dividends collected$638.00$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MCVEF vs KO ($10,000, DRIP)

YearMCVEF PortfolioMCVEF Income/yrKO PortfolioKO Income/yrGap
1← crossover$10,762$62.39$10,846$335.73$84.00KO
2$11,579$62.75$11,829$430.64$250.00KO
3$12,452$63.09$12,988$555.50$536.00KO
4$13,387$63.41$14,372$721.34$985.00KO
5$14,388$63.71$16,049$944.01$1.7KKO
6$15,459$64.00$18,114$1,246.74$2.7KKO
7$16,606$64.26$20,702$1,664.24$4.1KKO
8$17,832$64.51$24,008$2,249.48$6.2KKO
9$19,145$64.75$28,317$3,085.19$9.2KKO
10$20,551$64.97$34,065$4,303.79$13.5KKO

MCVEF vs KO: Complete Analysis 2026

MCVEFStock

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Full MCVEF Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this MCVEF vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCVEF vs SCHDMCVEF vs JEPIMCVEF vs OMCVEF vs MAINMCVEF vs PEPMCVEF vs PGMCVEF vs JNJMCVEF vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.